Godavari Biorefineries Reappoints Directors Following Shareholder Approval
Godavari Biorefineries Limited has announced the re-appointment of two key directors, Mr Nitin Mehta and Dr Sangeeta Srivastava, following a shareholder approval obtained through a Postal Ballot Notice on May 22, 2026.The company confirmed that these appointments are subject to shareholder approval. The board moved forward with the re-appointments of both individuals as part of its governance updates.
Mr Nitin Mehta was re-appointed as an Independent Director. His appointment tenure covers a period of five years, beginning from July 1, 2026. The company stated that there is no inter-se relationship between Mr Mehta and any other director. Furthermore, he has not been debarred from holding the office of Directors by virtue of any order passed by the Securities and Exchange Board of India or any other authority.
Dr Sangeeta Srivastava was re-appointed as a Whole Time Director, designated as an Executive Director. Her re-appointment term is set for three years, effective from August 1, 2026. Similar to Mr Mehta, Dr Srivastava has no inter-se relationship with any other director and is not debarred from holding the office of Directors by any authority.
The details of the directors and their respective terms are provided below:
| Particulars | Nitin Mehta (Independent Director) | Sangeeta Srivastava (Executive Director) |
|---|---|---|
| Reason for Change | Re-appointment | Re-appointment |
| Tenure Details | Five years, commencing from July 1, 2026 | Three years, commencing from August 1, 2026 |
| Relationship Disclosure | No inter-se relationship with any other director | No inter-se relationship with any other director |
GODAVARIB Stock Price Movement
Today, shares of Godavari Biorefineries Limited rallied, finishing at ₹287.9 after closing up 3.55%. The stock saw significant activity in the market, with 100,740 shares traded throughout the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.